Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices

UK regulatory approval follows FemaSeed, FemVue and FemCerv clearance/approvals in the U.S., Europe, Canada and Israel. Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women’s health worldwide, with a broad portfolio of disruptive, accessible in-office therapeutic and diagnostic products, announces… Read More

The Rage Group Announces Launch – A New Venture-Backed Model That’s Redefining Personal Branding for Entrepreneurs

Sophia Das and Hanna Lankler launch The Rage Group, a personal branding and venture studio combining strategic brand development with startup investments to help entrepreneurs build influence and scale their businesses. New York, New York, United States, 11th Feb 2025 – The Rage Group, a newly launched personal branding and venture… Read More